BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38303771)

  • 1. A 48-Year-Old Man With a Hip Fracture and Skin Rash: A Case Report.
    Parker JA; Hou R
    AACE Clin Case Rep; 2024; 10(1):2-6. PubMed ID: 38303771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
    Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
    Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid in osteoporosis secondary to mastocytosis.
    Rossini M; Zanotti R; Viapiana O; Tripi G; Idolazzi L; Biondan M; Orsolini G; Bonadonna P; Adami S; Gatti D
    Am J Med; 2014 Nov; 127(11):1127.e1-1127.e4. PubMed ID: 24954632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-endemic skeletal fluorosis: Causes and associated secondary hyperparathyroidism (case report and literature review).
    Cook FJ; Seagrove-Guffey M; Mumm S; Veis DJ; McAlister WH; Bijanki VN; Wenkert D; Whyte MP
    Bone; 2021 Apr; 145():115839. PubMed ID: 33418099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis.
    van der Veer E; Arends S; van der Hoek S; Versluijs JB; de Monchy JGR; Oude Elberink JNG; van Doormaal JJ
    J Allergy Clin Immunol; 2014 Dec; 134(6):1413-1421. PubMed ID: 24985401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.
    Guañabens N; Mumm S; Gifre L; Ruiz-Gaspà S; Demertzis JL; Stolina M; Novack DV; Whyte MP
    J Bone Miner Res; 2016 Sep; 31(9):1774-82. PubMed ID: 27005479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylactic shock during cement implantation of a total hip arthroplasty in a patient with underlying mastocytosis: case report of a rare intraoperative complication.
    Ten Hagen A; Doldersum P; van Raaij T
    Patient Saf Surg; 2016; 10():25. PubMed ID: 27822310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture Risk Reduction by Bisphosphonates in Mastocytosis?
    Onnes MC; van Doormaal JJ; van der Veer E; Versluijs JB; Arends S; Oude Elberink HNG
    J Allergy Clin Immunol Pract; 2020; 8(10):3557-3564. PubMed ID: 32673882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis.
    Kumar S; Chang R; Reyes M; Diamond T
    Arch Osteoporos; 2022 Oct; 17(1):131. PubMed ID: 36180610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral non-traumatic hip fractures in a heavy smoker COPD patient on inhaled steroids.
    Sanel S; Sezgin G; Sarıman N; Ugutmen E; Solakoglu C
    Arch Osteoporos; 2016; 11():8. PubMed ID: 26781126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femoral neck fractures after removal of hardware in healed trochanteric fractures.
    Barquet A; Giannoudis PV; Gelink A
    Injury; 2017 Dec; 48(12):2619-2624. PubMed ID: 29223594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporotic spinal burst fracture in a young adult as first presentation of systemic mastocytosis.
    Ble C; Tsitsopoulos PP; Anestis DM; Hadjileontiadou S; Koletsa T; Papaioannou M; Tsonidis C
    J Surg Case Rep; 2016 May; 2016(4):. PubMed ID: 27141048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis as the sole manifestation of systemic mastocytosis in a young man.
    Abramowitz JD; Weinerman SA
    Endocr Pract; 2012; 18(6):e158-61. PubMed ID: 23246689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient osteoporosis of the hip with a femoral neck fracture during follow-up: a case report.
    Tabata Y; Matsui S; Miyamoto M; Omori K; Tabata Y; Majima T
    J Yeungnam Med Sci; 2023 Apr; 40(2):212-217. PubMed ID: 36153877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series.
    Orsolini G; Gavioli I; Tripi G; Viapiana O; Gatti D; Idolazzi L; Zanotti R; Rossini M
    Calcif Tissue Int; 2017 Jun; 100(6):595-598. PubMed ID: 28229176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traumatic fracture in a healthy man: benign or pathologic?
    Nora EH; Kennel KA; Christian RC
    Endocr Pract; 2006; 12(5):552-8. PubMed ID: 17002931
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.